Oral e-Poster Presentations - Booth 3: Neuro-Oncology B (Meningiomas & Metastasis)
Tracks
Ground Floor
| Tuesday, September 26, 2023 |
| 1:00 PM - 2:30 PM |
| Ground floor - Booth 3 |
Details
Oral e-Posters: 3 minutes presentation duration
Speakers & Chairs
Dr Christine Jungk
Senior Consultant
University Hospital Heidelberg
Chair
Prof Rachel Grossman
Vice Chair
Rambam Health Care Campus
Chair
Dr Vladimír Beneš
Head
Second Faculty of Medicine, Charles University and University Hospital Motol
Evaluation of the growth rates and related prognostic factors in radiation-induced meningiomas
Dr Maria Elisa Di Francesco
Germany
University Hospital Tübingen, Department of Neurosurgery
The role of p16 immunohistochemistry as a prognostic biomarker in meningiomas
Ms Lea Baumgart
Resident
University Medical Center Hamburg-Eppendorf, Germany
Single Brain Metastases – Prognostic factors and impact of surgical resection on overall survival
Prof. Dr. Karl-Michael Schebesch
Vice Head
Medical Center of the University of Regensburg, Germany
Sodium Fluorescein and YELLOW 560 nm filter for resection of cerebral metastases: Impact on resection quality and outcome
Dr Darius Kalasauskas
Consultant
University Medical Centre Of Johannes Gutenberg University, Mainz, Germany
Development of a prediction model for preoperative determination of WHO grade and tumour aggressiveness of intracranial meningiomas
Dr Tunc Ersoy
Resident
Universitätsklinikum OWL, Campus Bielefeld-Bethel
Modified Frailty Index (mFI) as a Survival and Functional Outcome Predictor in Older Patients Undergoing Surgery for Brain Metastases
Dr Daniele Armocida
Ph.d Student
Sapienza University Of Rome
Radiological and surgical aspects of Polymorphous low-grade neuroepithelial tumor of the young (PLNTY). Study analysis of new histological entity
Dr Aleksandrs Krigers
Consultant
Medical University of Innsbruck
Clinical Frailty Scale and Karnofsky Performance Status are Superior to Temporal Muscle Thickness in Survival Prediction in Brain Metastasis Patients
Dr Andrea Maier
Researcher
Rigshospitalet
Spatial Transcriptomics of Brain Invasive Meningiomas Show Distinct TAM Profiles
Dr Anamaria Gheorghiu
MD
Spitalul Clinic De Urgenta "bagdasar-arseni"
Metabolic Factors, Life-style and Risk for Meningioma in Women: Results from the Cohort of Norway (CONOR)
Dr Dorothee Spille
Resident
University hospital Muenster
Molecular predictors for decitabine efficacy in meningiomas – a pilot study.
Dr Michael Ivan
Neurosurgeon
University Of Miami
Defining progressive disease in brain metastasis following laser interstitial thermal therapy
Dr Jordina Rincon-Torroella
Neurosurgery Resident
Johns Hopkins
Epidemiology, Prognostic Factors, and Survival Outcomes of Patients with Synchronous Brain Metastases: a 2015-2019 Population-based Study
Ms Bianca Dijkstra
MD, PhD candidate
University of Groningen, University Medical Centre Groningen
Fluorescence guided surgery for the detection of meningioma using bevacizumab-IRDye800CW (LUMINA trial) - a single center phase I/II study
Prof Christoph Schwartz
Attending Neurosurgeon
Paracelsus Medical University Salzburg
Surgical Outcome Of Supratentorial Meningioma Patients Aged ≥80 Years – Retrospective International Multicenter Study
Mr Luis Padevit
Resident
University Hospital of Zurich
A Prognostic Model For Tumor Recurrence And Progression After Meningioma Surgery: Preselection For Further Molecular Work
Dr Jun MUTO
Associate Professor
Fujita health university
Intraoperative real-time near-infrared image-guided surgery to identify intracranial meningioma
Dr Sumit Rajput
Ph.D. Student
Bharati Vidyapeeth (Deemed to be University) Medical College
Antitumor and protective efficacy of silver nanoparticles synthesized from Eclipta prostrate in an animal model of glioblastoma multiforme
Mr Panagiotis Papadopoulos-Manolarakis
Locum Consultant Neurosurgeon
General Hospital of Nikaia-Piraeus "Ag. Panteleimon"
Delayed Diagnosis of Brain Tumors Initially Presenting with Atypical Psychiatric Manifestations
Ms Selma Al-Ahmad
Registrar
Sheffield Teaching Hospitals
Are We Too Aggressive With Our Surgical Treatment Of Brain Metastases? A Single Centre Experience Over 2 years.
Dr Evangelia Konstantinidou
Undergraduate Student
Faculty Of Medicine, Aristotle University Of Thessaloniki, Greece.
Imaging And Clinical Evolution of Postoperative Ischemia Following Glioma Resection
Dr Alberto Franzin
Head Gamma Knife Unit
Fondazione Poliambulanza
Post Surgical Management of WHO Grade II Meningiomas: the Role of Gamma Knife and a Literature Review
Dr Morten Engsig
Junior Consultant
DNKS
Risk Factors For Early Death After Surgical Treatment Of Cerebral Metastases
Mr Schahin Salmanian
MD Student
University Of Duisburg-Essen
Novel Algorithm for Predicting Brain Metastases in Non-Small Cell Lung Cancer Patients. A Systematic Review and Independent Cohort Validation Analysis
